Cholecystokinin (CCK)‐33 Stimulates Insulin Secretion from the Perfused Rat Pancreas: Studies on the Structure‐Activity Relationship
- 1 July 1988
- journal article
- research article
- Published by Wiley in Basic & Clinical Pharmacology & Toxicology
- Vol. 63 (1) , 42-45
- https://doi.org/10.1111/j.1600-0773.1988.tb00907.x
Abstract
Cholecystokinin (CCK)-33 is known to stimulate insulin secretion. Presently, using the perfused rat pancreas, we have characterized the active site in the CCK-33 molecule that is responsible for this effect by the use of different CCK fragments. We found that CCK-33, CCK-8 and CCK-7 (1 nM) all significantly stimulated insulin secretion in the presence of 4.4 mM or 6.7 mM glucose. However, CCK-7 was much less potent than the longer forms. In contrast, CCK-4, CCK-6 and CCK-33 (1-21) had no effect on insulin secretion. We conclude that the shortest CCK-form that stimulates insulin secretion at 1 nM is the C-terminal heptapeptide CCK-7. However, CCK-8 is much more potent than CCK-7 in this respect.Keywords
This publication has 23 references indexed in Scilit:
- Effects of Six Cholecystokinin (CCK) Fragments on Insulin Secretion in the MouseActa Pharmacologica et Toxicologica, 2009
- Evidence that cholecystokinin interacts with specific receptors and regulates insulin release in isolated rat islets of LangerhansDiabetes, 1986
- Localization of saturable CCK binding sites in rat pancreatic islets by light and electron microscope autoradiographyDiabetes, 1985
- Cholecystokinin bioactivity in human plasma. Molecular forms, responses to feeding, and relationship to gallbladder contraction.Journal of Clinical Investigation, 1985
- Effects of two cholecystokinin variants, CCK-39 and CCK-8, on basal and stimulated insulin secretionActa Diabetologica, 1981
- Secretory effects of cholecystokinins on the isolated perfused porcine pancreasActa Physiologica Scandinavica, 1981
- Neural regulation of pancreatic hormone secretion by the C-terminal tetrapeptide of CCKNature, 1980
- IDENTIFICATION OF CHOLECYSTOKININ-SECRETING CELLSThe Lancet, 1975
- Etude expérimentale d'un nouveau sulfamide hypoglycémiant particulièrement actif, le HB 419 ou glibenclamideDiabetologia, 1969
- The Effects of Secretin, Pancreozymin, and Gastrin on Insulin and Glucagon Secretion in Anesthetized Dogs *Journal of Clinical Investigation, 1967